Late mortality and second cancers in an Australian cohort of childhood cancer survivors
- 6 September 2010
- journal article
- research article
- Published by AMPCo in Medical Journal of Australia
- Vol. 193 (5) , 258-261
Abstract
Objective: The aim of this study was to characterise rates of late mortality and second cancers in an Australian cohort of childhood cancer survivors and compare these to rates observed in the New South Wales population. Design, setting and participants: Records for 896 childhood cancer survivors treated at the Sydney Children's Hospital between 1972 and 1999 were linked to the National Death Index and NSW Central Cancer Registry to identify deaths and notifications of second cancers. Survivors were defined as those alive for at least 5 years after diagnosis and were followed until death or 31 December 2004, whichever occurred first. Main outcome measures: Standardised mortality ratios (SMRs) and standardised incidence ratios (SIRs) were used as measures of relative risk. A Cox proportional hazard model was used to quantify the influence of demographic and disease‐related characteristics on the risk of death and second cancers. Results: The SMR and SIR were 7.46 and 4.98 times higher, respectively, among cancer survivors relative to the NSW population. Relative mortality was highest in survivors of soft‐tissue sarcoma (SMR, 18.95 [95% CI, 6.88–40.81]) and central nervous system (CNS) malignancies (SMR, 16.78 [95% CI, 7.62–31.64]). The leading causes of death included recurrence of the primary childhood cancer (55%) and second cancers (12%), as well as treatment‐related complications (17%) The most frequently observed second cancers were bone and thyroid cancers, melanoma, and CNS malignancies, and second cancers were most common among survivors of leukaemia, soft‐tissue sarcoma and Hodgkin's lymphoma. Conclusions: Compared with the general population, survivors of childhood cancer in Australia are at increased risk of late mortality and second cancers. These findings highlight a continuing need to assess health issues faced by childhood cancer survivors and develop strategies to minimise the adverse outcomes associated with treatment for childhood cancer.Keywords
This publication has 22 references indexed in Scilit:
- Second Neoplasms in Survivors of Childhood Cancer: Findings From the Childhood Cancer Survivor Study CohortJournal of Clinical Oncology, 2009
- Late Mortality Among 5-Year Survivors of Childhood Cancer: A Summary From the Childhood Cancer Survivor StudyJournal of Clinical Oncology, 2009
- Cause-Specific Late Mortality Among 5-Year Survivors of Childhood Cancer: The Childhood Cancer Survivor StudyJNCI: Journal of the National Cancer Institute, 2008
- Risk of second malignant neoplasms after childhood central nervous system malignant tumours: An international studyEuropean Journal of Cancer, 2008
- Risk of Second Malignant Neoplasms After Childhood Leukemia and Lymphoma: An International StudyJNCI: Journal of the National Cancer Institute, 2007
- Mortality among 5‐year survivors of cancer diagnosed during childhood or adolescence in British Columbia, CanadaPediatric Blood & Cancer, 2007
- Risk of second malignancies in long-term survivors of childhood cancerEuropean Journal of Cancer, 2007
- Long-term outcomes of adult survivors of childhood cancerCancer, 2005
- Long‐term cause‐specific mortality among five‐year survivors of childhood cancerPediatric Blood & Cancer, 2004
- Second malignant neoplasms after cancer in childhood or adolescence. Nordic Society of Paediatric Haematology and Oncology Association of the Nordic Cancer Registries.BMJ, 1993